Achieve Life Sciences (ACHV) Current Assets (2010 - 2026)
Achieve Life Sciences' (ACHV) quarterly Current Assets came in at $31.1 million in Q1 2026, up 24.24% YoY from $25.0 million in Q1 2025, and down 22.13% on a QoQ basis from $39.9 million in Q4 2025.
Achieve Life Sciences (ACHV) Current Assets (2010 - 2026) Analysis & Trends
Achieve Life Sciences (ACHV) has 17 years of Current Assets data on file, last reported at $31.1 million in Q1 2026.
- Quarterly Current Assets rose 24.24% year-over-year to $31.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31.1 million (up 24.24% YoY) and the FY2025 annual result came in at $39.9 million, up 9.38% from the prior year.
- Current Assets eased to $31.1 million in Q1 2026, from $39.9 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $67.7 million in Q1 2024 to a low of $17.0 million in Q4 2023.
- A 5-year average of $36.2 million and a median of $31.1 million in 2022 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2024 — Current Assets surged 271.54% — and 2025, when it plunged 63.08%.
- Tracing ACHV's Current Assets over 5 years: stood at $27.3 million in 2022, then sank by 37.86% to $17.0 million in 2023, then surged by 114.74% to $36.5 million in 2024, then gained by 9.38% to $39.9 million in 2025, then retreated by 22.13% to $31.1 million in 2026.
- The last three Current Assets figures came in at $31.1 million (Q1 2026), $39.9 million (Q4 2025), and $50.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Achieve Life Sciences | 330.88 Mn | 330.88 Mn | - | 188.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 188.29 Mn |
| Mar 31, 2026 | 31.06 Mn |
| Dec 31, 2025 | 39.89 Mn |
| Sep 30, 2025 | 50.06 Mn |
| Jun 30, 2025 | 56.90 Mn |
| Mar 31, 2025 | 25.00 Mn |
| Dec 31, 2024 | 36.47 Mn |
| Sep 30, 2024 | 45.53 Mn |
| Jun 30, 2024 | 62.52 Mn |
| Mar 31, 2024 | 67.71 Mn |
| Dec 31, 2023 | 16.98 Mn |
| Sep 30, 2023 | 21.90 Mn |
| Jun 30, 2023 | 26.38 Mn |
| Mar 31, 2023 | 18.22 Mn |
| Dec 31, 2022 | 27.33 Mn |
| Sep 30, 2022 | 20.96 Mn |
| Jun 30, 2022 | 31.15 Mn |
| Mar 31, 2022 | 37.69 Mn |
| Dec 31, 2021 | 44.59 Mn |
| Sep 30, 2021 | 34.73 Mn |